...
首页> 外文期刊>Physics in medicine and biology. >Molecular image-directed biopsies: improving clinical biopsy selection in patients with multiple tumors
【24h】

Molecular image-directed biopsies: improving clinical biopsy selection in patients with multiple tumors

机译:分子图像定向活检:改善多发肿瘤患者的临床活检选择

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Site selection for image-guided biopsies in patients with multiple lesions is typically based on clinical feasibility and physician preference. This study outlines the development of a selection algorithm that, in addition to clinical requirements, incorporates quantitative imaging data for automatic identification of candidate lesions for biopsy. The algorithm is designed to rank potential targets by maximizing a lesion-specific score, incorporating various criteria separated into two categories: (1) physician-feasibility category including physician-preferred lesion location and absolute volume scores, and (2) imaging-based category including various modality and application-specific metrics. This platform was benchmarked in two clinical scenarios, a pre-treatment setting and response-based setting using imaging from metastatic prostate cancer patients with high disease burden (multiple lesions) undergoing conventional treatment and receiving whole-body [F-18]NaF PET/CT scans pre-and mid-treatment. Targeting of metastatic lesions was robust to different weighting ratios and candidacy for biopsy was physician confirmed. Lesion ranked as top targets for biopsy remained so for all patients in pretreatment and post-treatment biopsy selection after sensitivity testing was completed for physician-biased or imaging-biased scenarios. After identifying candidates, biopsy feasibility was evaluated by a physician and confirmed for 90% (32/36) of high-ranking lesions, of which all top choices were confirmed. The remaining cases represented lesions with high anatomical difficulty for targeting, such as proximity to sciatic nerve. This newly developed selection method was successfully used to quantitatively identify candidate lesions for biopsies in patients with multiple lesions. In a prospective study, we were able to successfully plan, develop, and implement this technique for the selection of a pre-treatment biopsy location.
机译:在具有多个病变的患者中进行图像引导活检的部位选择通常基于临床可行性和医生的偏爱。这项研究概述了选择算法的发展,除临床要求外,该算法还结合了定量成像数据以自动识别活检候选病变。该算法旨在通过最大化病变特定评分,将各种标准分为两类来对潜在目标进行排名:(1)医师可行性类别,包括医师偏爱的病变位置和绝对体积分数;(2)基于影像的类别包括各种模式和针对特定应用的指标。该平台已在两个临床场景中进行了基准测试,即治疗前设置和基于反应的设置,该设置来自具有高疾病负担(多个病变)的转移性前列腺癌患者,接受常规治疗并接受全身[F-18] NaF PET / CT扫描治疗前和治疗中。对于不同的权重比,转移灶的靶向性很强,医师已证实可以进行活检。病变仍然是活检的首要目标,因此,在针对医师偏倚或影像偏倚的情况下完成敏感性测试后,所有患者在治疗前和治疗后的活检中均应选择。在确定候选人之后,医生会评估活检的可行性,并确认90%(32/36)的高级别病灶,其中所有顶级选择均得到确认。其余病例表现为具有较高解剖难度的靶向病变,例如靠近坐骨神经。这种新开发的选择方法已成功用于定量鉴定具有多个病变的患者的活检候选病变。在一项前瞻性研究中,我们能够成功地计划,开发和实施此技术,以选择治疗前的活检位置。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号